|
WO2020127499A2
|
|
Mirnas as biomarkers for parkinson's syndrome
|
|
WO2019180153A1
|
|
Mir-34a modulating compounds in the therapy of diseases
|
|
CN111511929A
|
|
MiRNAs as biomarkers for Alzheimer's disease
|
|
US2020208219A1
|
|
Mirnas as biomarkers for parkinson's disease
|
|
WO2019002536A1
|
|
Novel mirna biomarkers and use thereof
|
|
EP3516074A1
|
|
Mirnas as non-invasive biomarkers for breast cancer
|
|
SG11201806794RA
|
|
Purification of rna fractions using a hydrophilic polymeric material
|
|
CN108026532A
|
|
New MIRNA biomarkers and application thereof
|
|
EP3265580A1
|
|
Signature of health
|
|
EP3212803A1
|
|
Mirnas as non-invasive biomarkers for inflammatory bowel disease
|
|
EP3146069A1
|
|
Determination of mir-423-5p in heart failure
|
|
EP3083987A2
|
|
Determination of platelet-mirnas in alzheimer's disease
|
|
EP2834372A1
|
|
Complex sets of mirnas as non-invasive biomarkers for early diagnosis of acute myocardial infarction
|
|
EP3360977A2
|
|
Mi-rna based treatment monitoring in multiple sclerosis
|
|
EP2744910A1
|
|
Complex sets of mirnas as non-invasive biomarkers for kidney cancer
|
